[Effect of corglycon and vasoactive agents on systemic and cerebral hemodynamics in cerebral infarct].
D000368:Aged; D002544:Cerebral Infarction / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D002560:Cerebrovascular Circulation / Q000187:drug effects; D004176:Dipyridamole / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009200:Myocardial Contraction / Q000187:drug effects; D013328:Strophanthins / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*; D014748:Vinca Alkaloids / Q000627:therapeutic use*
D013328:Strophanthins; D014665:Vasodilator Agents; D014748:Vinca Alkaloids; C013983:vinpocetine; D004176:Dipyridamole; C000505:convallatoxin
Vliianie korglikona i nekotorykh vazoaktivnykh sredstv na sistemnuiu i mozgovuiu gemodinamiku pri infarkte mozga.